AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

BTI · NYSE · Tobacco

British American Tobacco (ADR) (BTI)

Sells cigarettes alongside Vuse vapour, glo heated tobacco, and Velo oral nicotine.

$55.69

vs last close−0.06 (−0.10%)

In millions of USD, except per-share figures · converted from GBP at the latest rate

In millions	Q4 FY20Dec 2020	Q2 FY21Jun 2021	Q4 FY21Dec 2021	Q2 FY22Jun 2022	Q4 FY22Dec 2022	Q2 FY23Jun 2023	Q4 FY23Dec 2023	Q2 FY24Jun 2024	Q4 FY24Dec 2024	Q2 FY25Jun 2025	Q4 FY25Dec 2025	Q2 FY26Jun 2026
Revenue	18,005	16,232	18,010	17,157	19,713	17,919	18,454	16,452	18,034	16,090	18,053	16,432
Cost of revenue	3,264	2,833	3,296	2,870	3,534	2,992	3,529	2,885	3,029	2,641	2,993	6,726
Gross profit	14,741	13,399	14,714	14,286	16,178	14,928	14,925	13,567	15,005	13,449	15,060	9,706
	8,024	6,578	7,405	4,564	7,053	7,015	43,837	7,890	17,034	6,691	8,490	3,427
Research & development	227	189	216	200	231	259	285	224	283	232	232	0
	3,317	1,722	3,354	1,706	3,398	1,852	3,286	1,833	3,434	1,950	3,649	3,554
Selling & marketing	1,461	0	1,656	0	1,547	0	1,536	0	1,481	0	1,456	0
General & administrative	1,856	0	1,698	0	1,852	0	1,750	1,833	1,953	0	2,193	0
Other expenses	195	136	125	56	3,424	4,905	40,265	5,833	13,317	4,509	4,609	−126
Operating income	7,826	6,749	7,916	4,903	9,126	7,912	−28,912	5,677	−2,029	6,758	6,570	6,279
	1,295	−1,245	−1,195	−823	−776	−843	−904	1,789	−720	673	−857	−837
Interest income	1,277	976	939	501	27	113	135	317	317	0	131	114
Interest expense	0	0	0	1,460	1,071	1,204	1,376	2,402	939	1,019	1,108	1,111
Other non-operating income	−2,390	249	200	445	−1,060	4	−37,707	−5	−4,703	−7	−692	0
Income before tax	5,439	5,845	6,371	4,081	8,350	7,070	−29,815	7,466	−2,749	7,431	5,713	5,442
Income tax expense	1,405	1,407	1,512	1,497	1,806	1,690	−5,519	1,388	−912	1,345	1,447	1,107
Net income from continuing operations	3,802	4,128	4,617	2,317	6,543	4,994	−24,296	6,078	−1,837	6,086	4,266	4,335
Other adjustments	232	311	227	0	0	0	0	0	0	0	0	0
Net income	3,924	4,333	4,718	2,478	6,409	5,278	−24,432	5,989	−1,898	6,015	4,336	4,284
EPS, basic	$1.72	$1.89	$2.07	$1.08	$2.83	$2.36	−$10.97	$2.67	−$0.88	$2.72	$1.93	$1.96
EPS, diluted	$1.71	$1.89	$2.05	$1.08	$2.81	$2.35	−$10.97	$2.67	−$0.88	$2.72	$1.93	$1.95
Weighted average shares, basic	2,286	2,287	2,288	2,262	2,254	2,229	2,230	2,232	2,202	2,205	2,193	2,165
Weighted average shares, diluted	2,296	2,296	2,298	2,273	2,261	2,237	2,230	2,232	2,202	2,205	2,193	2,176
EBITDA	7,065	7,166	7,860	5,645	10,447	8,556	9,000	7,842	2,473	8,258	8,550	8,111
Depreciation & amortization	761	636	737	704	261	640	205	2,160	1,974	1,493	1,288	1,832
EBIT	6,303	6,530	7,123	5,349	10,186	7,916	8,795	5,682	499	6,765	7,262	6,279